James A. Linn
James A. Linn publishes mostly in Organic Chemistry, Molecular Biology and Epidemiology, on topics such as Synthesis and Biological Evaluation, Chemical Synthesis and Analysis and HIV/AIDS drug development and treatment.
- World rank
- #6,335,473 of 7,710,434 ranked researchers
- Rank in United States
- #1,505,687 of 1,627,098
- Works
- 19
- Citations
- 358
- Citations per work
- 18.8
What does James A. Linn research?
James A. Linn's work is mostly in Chemistry (33%), Medicine (23%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences633.3%
- Chemistry633.3%
- Health Sciences422.8%
- Medicine422.8%
- Everything else422.8%
- Life Sciences421.1%
- 1Organic Chemistry33% of their works
- 2Molecular Biology16% of their works
- 3Epidemiology10% of their works
- 4Infectious Diseases7% of their works
- 5Pediatrics, Perinatology and Child Health5% of their works
- 6Physiology5% of their works
Research topics
- Synthesis and Biological Evaluation
- Chemical Synthesis and Analysis
- HIV/AIDS drug development and treatment
- Adenosine and Purinergic Signaling
- Synthesis and Characterization of Heterocyclic Compounds
- Cytomegalovirus and herpesvirus research
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthetic Organic Chemistry Methods
Which keywords describe James A. Linn's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Drug Discovery, Anticancer, Antimicrobial, Antimicrobial Activity, Quinoxaline and Antiretroviral Therapy.
- Phenothiazines
- Biological Activities
- Scaffold
- Infection
- Adenosine Receptors
- HIV Infection
- Antiretroviral Therapy
- Antimicrobial Activity
- Anticancer
- Biological Evaluation
- Synthesis
- Drug Discovery
- Antimicrobial
- Quinoxaline
- Foldamers
- Peptide Synthesis
- Cytomegalovirus
- Purinergic Signalling
- Triazines
- Olefin Metathesis
- Ruthenium Catalysts
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis103 topics
- Biological Evaluation82 topics
- Drug Discovery72 topics
- Anticancer52 topics
- Antimicrobial52 topics
- Antimicrobial Activity51 topic
- Quinoxaline51 topic
- Antiretroviral Therapy41 topic
- Foldamers41 topic
- HIV Infection41 topic
- Peptide Synthesis41 topic
- Adenosine Receptors31 topic
- Cytomegalovirus31 topic
- Infection31 topic
- Purinergic Signalling31 topic
- Scaffold31 topic
- Triazines31 topic
- Biological Activities21 topic
- Olefin Metathesis21 topic
- Phenothiazines21 topic
- Ruthenium Catalysts21 topic
Where does James A. Linn work?
James A. Linn's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does James A. Linn have?
OpenAlex counts 19 works and 358 citations for James A. Linn, an h-index of 11, ranking #6,335,473 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named James A. Linn
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James A. Linn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.